New insights into behaviour using mouse enu mutagenesis

Human Molecular Genetics

Volumn 21, Issue R1, 2012, Pages

  Oliver, Peter L ^a   Davies, Kay E ^a  

^a UNIVERSITY OF OXFORD   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

DISRUPTED IN SCHIZOPHRENIA 1 PROTEIN; ETHYLNITROSOUREA; PERIPHERAL MYELIN PROTEIN 22; TRANSIENT RECEPTOR POTENTIAL CHANNEL 3;

ARTICLE; BEHAVIOR DISORDER; CIRCADIAN RHYTHM; GENE DELETION; GENE EXPRESSION; GENE PRODUCT; GENETIC HETEROGENEITY; GENETIC VARIABILITY; GENOTYPE PHENOTYPE CORRELATION; MENTAL DISEASE; MOTOR DYSFUNCTION; MOUSE; MUTAGENESIS; NERVE DEGENERATION; NONHUMAN; PHENOTYPE; POINT MUTATION; PRIORITY JOURNAL;

ANIMALS; BEHAVIOR; BEHAVIORAL SYMPTOMS; BIOLOGICAL MARKERS; CIRCADIAN RHYTHM; DATABASES, GENETIC; ETHYLNITROSOUREA; GENETICS, BEHAVIORAL; MENTAL DISORDERS; MICE; MUTAGENESIS; MUTATION; NERVOUS SYSTEM DISEASES; POINT MUTATION;

MAMMALIA;

EID: 84867115579     PISSN: 09646906     EISSN: 14602083     Source Type: Journal    
DOI: 10.1093/hmg/dds318     Document Type: Article

References (138)

1. Marian, A.J. (2012) Molecular genetic studies of complex phenotypes. Trans. Res., 159, 64-79.
2. Bras, J., Guerreiro, R. and Hardy, J. (2012) Use of next-generation sequencing and other whole-genome strategies to dissect neurological disease. Nat. Rev. Neurosci., 13, 453-464.
3. Trancikova, A., Ramonet, D. and Moore, D.J. (2011) Genetic mouse models of neurodegenerative diseases. Prog. Mol. Biol. Trans. Sci., 100, 419-482.
4. Rosenthal, N. and Brown, S. (2007) The mouse ascending: perspectives for human-disease models. Nat. Cell Biol., 9, 993-999.
5. Arguello, P.A. and Gogos, J.A. (2006) Modeling madness in mice: one piece at a time. Neuron, 52, 179-196.
6. Crawley, J.N. (2008) Behavioral phenotyping strategies for mutant mice. Neuron, 57, 809-818.
7. Skarnes, W.C., Rosen, B., West, A.P., Koutsourakis, M., Bushell, W., Iyer, V., Mujica, A.O., Thomas, M., Harrow, J., Cox, T. et al. (2011) A conditional knockout resource for the genome-wide study of mouse gene function. Nature, 474, 337-342.
8. Guan, C., Ye, C., Yang, X. and Gao, J. (2010) A review of current large-scale mouse knockout efforts. Genesis, 48, 73-85.
9. Elsea, S.H. and Lucas, R.E. (2002) The mousetrap: what we can learn when the mouse model does not mimic the human disease. ILAR J., 43, 66-79.
10. Amberger, J., Bocchini, C. and Hamosh, A. (2011) A new face and new challenges for Online Mendelian Inheritance in Man (OMIM(R)). Hum. Mutat., 32, 564-567.
11. Barbaric, I., Miller, G. and Dear, T.N. (2007) Appearances can be deceiving: phenotypes of knockout mice. Brief Funct. Genomic Proteomic, 6, 91-103.
12. Justice, M.J., Noveroske, J.K., Weber, J.S., Zheng, B. and Bradley, A. (1999) Mouse ENU mutagenesis. Hum. Mol. Genet., 8, 1955-1963.
13. Brown, S.D. and Nolan, P.M. (1998) Mouse mutagenesis-systematic studies of mammalian gene function. Hum. Mol. Genet., 7, 1627-1633.
14. Nolan, P.M., Peters, J., Strivens, M., Rogers, D., Hagan, J., Spurr, N., Gray, I.C., Vizor, L., Brooker, D., Whitehill, E. et al. (2000) A systematic, genome-wide, phenotype-driven mutagenesis programme for gene function studies in the mouse. Nat. Genet., 25, 440-443.
15. Hrabe de Angelis, M.H., Flaswinkel, H., Fuchs, H., Rathkolb, B., Soewarto, D., Marschall, S., Heffner, S., Pargent, W., Wuensch, K., Jung, M. et al. (2000) Genome-wide, large-scale production of mutant mice by ENU mutagenesis. Nat. Genet., 25, 444-447.
16. Acevedo-Arozena, A., Wells, S., Potter, P., Kelly, M., Cox, R.D. and Brown, S.D. (2008) ENU mutagenesis, a way forward to understand gene function. Annu. Rev. Genomics Hum. Genet., 9, 49-69.
17. Cordes, S.P. (2005) N-ethyl-N-nitrosourea mutagenesis: boarding the mouse mutant express. Microbiol. Mol. Biol. Rev., 69, 426-439.
18. Rogers, D.C., Fisher, E.M., Brown, S.D., Peters, J., Hunter, A.J. and Martin, J.E. (1997) Behavioral and functional analysis of mouse phenotype: SHIRPA, a proposed protocol for comprehensive phenotype assessment. Mamm. Genome, 8, 711-713.
19. Masuya, H., Inoue, M., Wada, Y., Shimizu, A., Nagano, J., Kawai, A., Inoue, A., Kagami, T., Hirayama, T., Yamaga, A. et al. (2005) Implementation of the modified-SHIRPA protocol for screening of dominant phenotypes in a large-scale ENU mutagenesis program. Mamm. Genome, 16, 829-837.
20. Clark, A.T., Goldowitz, D., Takahashi, J.S., Vitaterna, M.H., Siepka, S.M., Peters, L.L., Frankel, W.N., Carlson, G.A., Rossant, J., Nadeau, J.H. et al. (2004) Implementing large-scale ENU mutagenesis screens in North America. Genetica, 122, 51-64.
21. Boles, M.K., Wilkinson, B.M., Wilming, L.G., Liu, B., Probst, F.J., Harrow, J., Grafham, D., Hentges, K.E., Woodward, L.P., Maxwell, A. et al. (2009) Discovery of candidate disease genes in ENU-induced mouse mutants by large-scale sequencing, including a splice-site mutation in nucleoredoxin. PLoS Genet., 5, e1000759.
22. Sun, M., Mondal, K., Patel, V., Horner, V.L., Long, A.B., Cutler, D.J., Caspary, T. and Zwick, M.E. (2012) Multiplex chromosomal exome sequencing accelerates identification of ENU-induced mutations in the mouse. G3 (Bethesda), 2, 143-150.
23. Sheridan, R., Lampe, K., Shanmukhappa, S.K., Putnam, P., Keddache, M., Divanovic, S., Bezerra, J. and Hoebe, K. (2011) Lampe1: an ENU-germline mutation causing spontaneous hepatosteatosis identified through targeted exon-enrichment and next-generation sequencing. PLoS ONE, 6, e21979.
24. Fuchs, H., Gailus-Durner, V., Adler, T., Aguilar-Pimentel, J.A., Becker, L., Calzada-Wack, J., Da Silva-Buttkus, P., Neff, F., Gotz, A., Hans, W. et al. (2011) Mouse phenotyping. Methods, 53, 120-135.
25. Beckers, J., Wurst, W. and de Angelis, M.H. (2009) Towards better mouse models: enhanced genotypes, systemic phenotyping and envirotype modelling. Nat. Rev. Genet., 10, 371-380.
26. Schofield, P.N., Vogel, P., Gkoutos, G.V. and Sundberg, J.P. (2012) Exploring the elephant: histopathology in high-throughput phenotyping of mutant mice. Dis. Model Mech., 5, 19-25.
27. Michaud, E.J., Culiat, C.T., Klebig, M.L., Barker, P.E., Cain, K.T., Carpenter, D.J., Easter, L.L., Foster, C.M., Gardner, A.W., Guo, Z.Y. et al. (2005) Efficient gene-driven germ-line point mutagenesis of C57BL/6J mice. BMC Genomics, 6, 164.
28. Gondo, Y., Fukumura, R., Murata, T. and Makino, S. (2010) ENU-based gene-driven mutagenesis in the mouse: a next-generation gene-targeting system. Exp. Anim., 59, 537-548.
29. Quwailid, M.M., Hugill, A., Dear, N., Vizor, L., Wells, S., Horner, E., Fuller, S., Weedon, J., McMath, H., Woodman, P. et al. (2004) A gene-driven ENU-based approach to generating an allelic series in any gene. Mamm. Genome, 15, 585-591.
30. Sakuraba, Y., Sezutsu, H., Takahasi, K.R., Tsuchihashi, K., Ichikawa, R., Fujimoto, N., Kaneko, S., Nakai, Y., Uchiyama, M., Goda, N. et al. (2005) Molecular characterization of ENU mouse mutagenesis and archives. Biochem. Biophys. Res. Commun., 336, 609-616.
31. Oliver, P.L., Bitoun, E. and Davies, K.E. (2007) Comparative genetic analysis: the utility of mouse genetic systems for studying human monogenic disease. Mamm. Genome, 18, 412-424.
32. Tucci, V., Lad, H.V., Parker, A., Polley, S., Brown, S.D. and Nolan, P.M. (2006) Gene-environment interactions differentially affect mouse strain behavioral parameters. Mamm. Genome, 17, 1113-1120.
33. Tecott, L.H. and Nestler, E.J. (2004) Neurobehavioral assessment in the information age. Nat. Neurosci., 7, 462-466.
34. Bailey, K.R., Rustay, N.R. and Crawley, J.N. (2006) Behavioral phenotyping of transgenic and knockout mice: practical concerns and potential pitfalls. ILAR J., 47, 124-131.
35. Deacon, R.M. (2006) Housing, husbandry and handling of rodents for behavioral experiments. Nat. Protoc., 1, 936-946.
36. Crabbe, J.C. and Morris, R.G. (2004) Festina lente: late-night thoughts on high-throughput screening of mouse behavior. Nat. Neurosci., 7, 1175-1179.
37. Brown, S.D., Chambon, P. and de Angelis, M.H. (2005) EMPReSS: standardized phenotype screens for functional annotation of the mouse genome. Nat. Genet., 37, 1155.
38. Fuchs, H., Gailus-Durner, V., Adler, T., Pimentel, J.A.A., Becker, L., Bolle, I., Brielmeier, M., Calzada-Wack, J., Dalke, C., Ehrhardt, N. et al. (2009) The German Mouse Clinic: a platform for systemic phenotype analysis of mouse models. Curr. Pharm. Biotechnol., 10, 236-243.
39. Cook, M.N., Dunning, J.P., Wiley, R.G., Chesler, E.J., Johnson, D.K., Miller, D.R. and Goldowitz, D. (2007) Neurobehavioral mutants identified in an ENU-mutagenesis project. Mamm. Genome, 18, 559- 572.
40. Wakana, S., Suzuki, T., Furuse, T., Kobayashi, K., Miura, I., Kaneda, H., Yamada, I., Motegi, H., Toki, H., Inoue, M. et al. (2009) Introduction to the Japan Mouse Clinic at the RIKEN BioResource Center. Exp. Anim., 58, 443-450.
41. Barreto, G., Huang, T.T. and Giffard, R.G. (2010) Age-related defects in sensorimotor activity, spatial learning, and memory in C57BL/6 mice. J. Neurosurg. Anesthesiol., 22, 214-219.
42. Baur, J.A., Pearson, K.J., Price, N.L., Jamieson, H.A., Lerin, C., Kalra, A., Prabhu, V.V., Allard, J.S., Lopez-Lluch, G., Lewis, K. et al. (2006) Resveratrol improves health and survival of mice on a high-calorie diet. Nature, 444, 337-342.
43. Kumar, V., Kim, K., Joseph, C., Thomas, L.C., Hong, H. and Takahashi, J.S. (2011) Second-generation high-throughput forward genetic screen in mice to isolate subtle behavioral mutants. Proc. Natl Acad. Sci. USA, 108, 15557-15564.
44. Godinho, S.I. and Nolan, P.M. (2006) The role of mutagenesis in defining genes in behaviour. Eur. J. Hum. Genet., 14, 651-659.
45. Falconer, D.S. (1951) 2 new mutants, trembler and reeler, with neurological actions in the house mouse (mus-musculus l). J. Genet., 50, 10.
46. Caddy, K.W. and Biscoe, T.J. (1975) Preliminary observations on the cerebllum in the mutant mouse Lurcher. Brain Res., 91, 276-280.
47. Isaacs, A.M., Davies, K.E., Hunter, A.J., Nolan, P.M., Vizor, L., Peters, J., Gale, D.G., Kelsell, D.P., Latham, I.D., Chase, J.M. et al. (2000) Identification of two new Pmp22 mouse mutants using large-scale mutagenesis and a novel rapid mapping strategy. Hum. Mol. Genet., 9, 1865-1871.
48. Isaacs, A.M., Jeans, A., Oliver, P.L., Vizor, L., Brown, S.D., Hunter, A.J. and Davies, K.E. (2002) Identification of a new Pmp22 mouse mutant and trafficking analysis of a Pmp22 allelic series suggesting that protein aggregates may be protective in Pmp22-associated peripheral neuropathy. Mol. Cell Neurosci., 21, 114-125.
49. Oliver, P.L. and Davies, K.E. (2005) Analysis of human neurological disorders using mutagenesis in the mouse. Clin. Sci. (Lond.), 108, 385- 397.
50. Durr, A. (2010) Autosomal dominant cerebellar ataxias: polyglutamine expansions and beyond. Lancet Neurol., 9, 885-894.
51. Matilla-Duenas, A., Sanchez, I., Corral-Juan, M., Davalos, A., Alvarez, R. and Latorre, P. (2010) Cellular and molecular pathways triggering neurodegeneration in the spinocerebellar ataxias. Cerebellum, 9, 148- 166.
52. Isaacs, A.M., Oliver, P.L., Jones, E.L., Jeans, A., Potter, A., Hovik, B.H., Nolan, P.M., Vizor, L., Glenister, P., Simon, A.K. et al. (2003) A mutation in Af4 is predicted to cause cerebellar ataxia and cataracts in the robotic mouse. J. Neurosci., 23, 1631-1637.
53. Prasad, R., Yano, T., Sorio, C., Nakamura, T., Rallapalli, R., Gu, Y., Leshkowitz, D., Croce, C.M. and Canaani, E. (1995) Domains with transcriptional regulatory activity within the ALL1 and AF4 proteins involved in acute leukemia. Proc. Natl Acad. Sci. USA, 92, 12160- 12164.
54. Isnard, P., Core, N., Naquet, P. and Djabali, M. (2000) Altered lymphoid development in mice deficient for the mAF4 proto-oncogene. Blood, 96, 705-710.
55. Oliver, P.L., Bitoun, E., Clark, J., Jones, E.L. and Davies, K.E. (2004) Mediation of Af4 protein function in the cerebellum by Siah proteins. Proc. Natl Acad. Sci. USA, 101, 14901-14906.
56. Bitoun, E., Oliver, P.L. and Davies, K.E. (2007) The mixed-lineage leukemia fusion partner AF4 stimulates RNA polymerase II transcriptional elongation and mediates coordinated chromatin remodeling. Hum. Mol. Genet., 16, 92-106.
57. Bitoun, E., Finelli, M.J., Oliver, P.L., Lee, S. and Davies, K.E. (2009) AF4 is a critical regulator of the IGF-1 signaling pathway during Purkinje cell development. J. Neurosci., 29, 15366-15374.
58. Croci, L., Barili, V., Chia, D., Massimino, L., van Vugt, R., Masserdotti, G., Longhi, R., Rotwein, P. and Consalez, G.G. (2011) Local insulin-like growth factor I expression is essential for Purkinje neuron survival at birth. Cell Death Differ., 18, 48-59.
59. Becker, E.B., Oliver, P.L., Glitsch, M.D., Banks, G.T., Achilli, F., Hardy, A., Nolan, P.M., Fisher, E.M. and Davies, K.E. (2009) A point mutation in TRPC3 causes abnormal Purkinje cell development and cerebellar ataxia in moonwalker mice. Proc. Natl Acad. Sci. USA, 106, 6706-6711.
60. Hartmann, J., Dragicevic, E., Adelsberger, H., Henning, H.A., Sumser, M., Abramowitz, J., Blum, R., Dietrich, A., Freichel, M., Flockerzi, V. et al. (2008) TRPC3 channels are required for synaptic transmission and motor coordination. Neuron, 59, 392-398.
61. Becker, E.B., Fogel, B.L., Rajakulendran, S., Dulneva, A., Hanna, M.G., Perlman, S.L., Geschwind, D.H. and Davies, K.E. (2011) Candidate screening of the TRPC3 gene in cerebellar ataxia. Cerebellum, 10, 296- 299.
62. Martin-Trujillo, A., Iglesias-Platas, I., Coto, E., Corral-Juan, M., San Nicolas, H., Corral, J., Volpini, V., Matilla-Duenas, A. and Monk, D. (2011) Genotype of an individual single nucleotide polymorphism regulates DNA methylation at the TRPC3 alternative promoter. Epigenetics, 6, 1236-1241.
63. Achilli, F., Bros-Facer, V., Williams, H.P., Banks, G.T., AlQatari, M., Chia, R., Tucci, V., Groves, M., Nickols, C.D., Seburn, K.L. et al. (2009) An ENU-induced mutation in mouse glycyl-tRNA synthetase (GARS) causes peripheral sensory and motor phenotypes creating a model of Charcot-Marie-Tooth type 2D peripheral neuropathy. Dis. Model Mech., 2, 359-373.
64. Seburn, K.L., Nangle, L.A., Cox, G.A., Schimmel, P. and Burgess, R.W. (2006) An active dominant mutation of glycyl-tRNA synthetase causes neuropathy in a Charcot-Marie-Tooth 2D mouse model. Neuron, 51, 715-726.
65. Motley, W.W., Seburn, K.L., Nawaz, M.H., Miers, K.E., Cheng, J., Antonellis, A., Green, E.D., Talbot, K., Yang, X.L., Fischbeck, K.H. et al. (2011) Charcot-Marie-Tooth-linked mutant GARS is toxic to peripheral neurons independent of wild-type GARS levels. PLoS Genet., 7, e1002399.
66. O'Tuathaigh, C.M., Desbonnet, L., Moran, P.M., Kirby, B.P. and Waddington, J.L. (2011) Molecular genetic models related to schizophrenia and psychotic illness: heuristics and challenges. Curr. Top. Behav. Neurosci., 7, 87-119.
67. Nestler, E.J. and Hyman, S.E. (2010) Animal models of neuropsychiatric disorders. Nat. Neurosci., 13, 1161-1169.
68. Papaleo, F., Lipska, B.K. and Weinberger, D.R. (2012) Mouse models of genetic effects on cognition: relevance to schizophrenia. Neuropharmacology, 62, 1204-1220.
69. Harrison, P.J., Pritchett, D., Stumpenhorst, K., Betts, J.F., Nissen, W., Schweimer, J., Lane, T., Burnet, P.W., Lamsa, K.P., Sharp, T. et al. (2012) Genetic mouse models relevant to schizophrenia: taking stock and looking forward. Neuropharmacology, 62, 1164-1167.
70. Porteous, D.J., Millar, J.K., Brandon, N.J. and Sawa, A. (2011) DISC1 at 10: connecting psychiatric genetics and neuroscience. Trends Mol. Med., 17, 699-706.
71. Clapcote, S.J., Lipina, T.V., Millar, J.K., Mackie, S., Christie, S., Ogawa, F., Lerch, J.P., Trimble, K., Uchiyama, M., Sakuraba, Y. et al. (2007) Behavioral phenotypes of Disc1 missense mutations in mice. Neuron, 54, 387-402.
72. Lipina, T.V., Kaidanovich-Beilin, O., Patel, S., Wang, M., Clapcote, S.J., Liu, F., Woodgett, J.R. and Roder, J.C. (2011) Genetic and pharmacological evidence for schizophrenia-related Disc1 interaction with GSK-3. Synapse, 65, 234-248.
73. Lee, F.H., Fadel, M.P., Preston-Maher, K., Cordes, S.P., Clapcote, S.J., Price, D.J., Roder, J.C. and Wong, A.H. (2011) Disc1 point mutations in mice affect development of the cerebral cortex. J. Neurosci., 31, 3197- 3206.
74. Shoji, H., Toyama, K., Takamiya, Y., Wakana, S., Gondo, Y. and Miyakawa, T. (2012) Comprehensive behavioral analysis of ENU-induced Disc1-Q31L and -L100P mutant mice. BMC Res. Notes, 5, 108.
75. Mandillo, S., Tucci, V., Holter, S.M., Meziane, H., Banchaabouchi, M.A., Kallnik, M., Lad, H.V., Nolan, P.M., Ouagazzal, A.M., Coghill, E.L. et al. (2008) Reliability, robustness, and reproducibility in mouse behavioral phenotyping: a cross-laboratory study. Physiol. Genomics, 34, 243-255.
76. Jeans, A.F., Oliver, P.L., Johnson, R., Capogna, M., Vikman, J., Molnar, Z., Babbs, A., Partridge, C.J., Salehi, A., Bengtsson, M. et al. (2007) A dominant mutation in Snap25 causes impaired vesicle trafficking, sensorimotor gating, and ataxia in the blind-drunk mouse. Proc. Natl Acad. Sci. USA, 104, 2431-2436.
77. Johnson, R.D., Oliver, P.L. and Davies, K.E. (2008) SNARE proteins and schizophrenia: linking synaptic and neurodevelopmental hypotheses. Acta Biochim. Pol., 55, 619-628.
78. Washbourne, P., Thompson, P.M., Carta, M., Costa, E.T., Mathews, J.R., Lopez-Bendito, G., Molnar, Z., Becher, M.W., Valenzuela, C.F., Partridge, L.D. et al. (2002) Genetic ablation of the t-SNARE SNAP-25 distinguishes mechanisms of neuroexocytosis. Nat. Neurosci., 5, 19-26.
79. Fanous, A.H., Zhao, Z., van den Oord, E.J., Maher, B.S., Thiselton, D.L., Bergen, S.E., Wormley, B., Bigdeli, T., Amdur, R.L., O'Neill, F.A. et al. (2010) Association study of SNAP25 and schizophrenia in Irish family and case-control samples. Am. J. Med. Genet. B Neuropsychiatr. Genet., 153B, 663-674.
80. Thompson, P.M., Egbufoama, S. and Vawter, M.P. (2003) SNAP-25 reduction in the hippocampus of patients with schizophrenia. Prog. Neuropsychopharmacol. Biol. Psychiatry, 27, 411-417.
81. Thompson, P.M., Sower, A.C. and Perrone-Bizzozero, N.I. (1998) Altered levels of the synaptosomal associated protein SNAP-25 in schizophrenia. Biol. Psychiatry, 43, 239-243.
82. Barakauskas, V.E., Beasley, C.L., Barr, A.M., Ypsilanti, A.R., Li, H.Y., Thornton, A.E., Wong, H., Rosokilja, G., Mann, J.J., Mancevski, B. et al. (2010) A novel mechanism and treatment target for presynaptic abnormalities in specific striatal regions in schizophrenia. Neuropsychopharmacology, 35, 1226-1238.
83. Gejman, P.V., Sanders, A.R. and Kendler, K.S. (2011) Genetics of schizophrenia: new findings and challenges. Annu. Rev. Genomics Hum. Genet., 12, 121-144.
84. Barnett, J.H. and Smoller, J.W. (2009) The genetics of bipolar disorder. Neuroscience, 164, 331-343.
85. Clapcote, S.J., Duffy, S., Xie, G., Kirshenbaum, G., Bechard, A.R., Rodacker Schack, V., Petersen, J., Sinai, L., Saab, B.J., Lerch, J.P. et al. (2009) Mutation I810N in the alpha3 isoform of Na+,K+-ATPase causes impairments in the sodium pump and hyperexcitability in the CNS. Proc. Natl Acad. Sci. USA, 106, 14085-14090.
86. Goldstein, I., Lerer, E., Laiba, E., Mallet, J., Mujaheed, M., Laurent, C., Rosen, H., Ebstein, R.P. and Lichtstein, D. (2009) Association between sodium- and potassium-activated adenosine triphosphatase alpha isoforms and bipolar disorders. Biol. Psychiatry, 65, 985-991.
87. Einholm, A.P., Toustrup-Jensen, M.S., Holm, R., Andersen, J.P. and Vilsen, B. (2010) The rapid-onset dystonia parkinsonism mutation D923N of the Na+, K+-ATPase alpha3 isoform disrupts Na+ interaction at the third Na+ site. J. Biol. Chem., 285, 26245-26254.
88. Kirshenbaum, G.S., Clapcote, S.J., Duffy, S., Burgess, C.R., Petersen, J., Jarowek, K.J., Yucel, Y.H., Cortez, M.A., Snead, O.C. 3rd, Vilsen, B. et al. (2011) Mania-like behavior induced by genetic dysfunction of the neuron-specific Na+,K+-ATPase alpha3 sodium pump. Proc. Natl Acad. Sci. USA, 108, 18144-18149.
89. Mula, M. (2010) The clinical spectrum of bipolar symptoms in epilepsy: a critical reappraisal. Postgrad. Med., 122, 17-23.
90. Brown, A.S. (2011) The environment and susceptibility to schizophrenia. Prog. Neurobiol., 93, 23-58.
91. van Os, J., Kenis, G. and Rutten, B.P. (2010) The environment and schizophrenia. Nature, 468, 203-212.
92. Oliver, P.L. (2011) Challenges of analysing gene-environment interactions in mouse models of schizophrenia. ScientificWorldJournal, 11, 1411-1420.
93. Meyer, U. and Feldon, J. (2010) Epidemiology-driven neurodevelopmental animal models of schizophrenia. Prog. Neurobiol., 90, 285-326.
94. Ayhan, Y., Sawa, A., Ross, C.A. and Pletnikov, M.V. (2009) Animal models of gene-environment interactions in schizophrenia. Behav. Brain Res., 204, 274-281.
95. Oliver, P.L. and Davies, K.E. (2009) Interaction between environmental and genetic factors modulates schizophrenic endophenotypes in the Snap-25 mouse mutant blind-drunk. Hum. Mol. Genet., 18, 4576-4589.
96. Haque, F.N., Lipina, T.V., Roder, J.C. and Wong, A.H. (2012) Social defeat interacts with Disc1 mutations in the mouse to affect behavior. Behav. Brain Res., 233, 337-344.
97. Wulff, K., Gatti, S., Wettstein, J.G. and Foster, R.G. (2010) Sleep and circadian rhythm disruption in psychiatric and neurodegenerative disease. Nat. Rev. Neurosci., 11, 589-599.
98. Bassetti, C.L. (2011) Nonmotor disturbances in Parkinson's disease. Neurodegener. Dis., 8, 95-108.
99. Naismith, S.L., Lewis, S.J. and Rogers, N.L. (2011) Sleep-wake changes and cognition in neurodegenerative disease. Prog. Brain Res., 190, 21-52.
100. Siepka, S.M. and Takahashi, J.S. (2005) Methods to record circadian rhythm wheel running activity in mice. Methods Enzymol., 393, 230-239.
101. Bacon, Y., Ooi, A., Kerr, S., Shaw-Andrews, L., Winchester, L., Breeds, S., Tymoska-Lalanne, Z., Clay, J., Greenfield, A.G. and Nolan, P.M. (2004) Screening for novel ENU-induced rhythm, entrainment and activity mutants. Genes Brain Behav., 3, 196-205.
102. Godinho, S.I., Maywood, E.S., Shaw, L., Tucci, V., Barnard, A.R., Busino, L., Pagano, M., Kendall, R., Quwailid, M.M., Romero, M.R. et al. (2007) The after-hours mutant reveals a role for Fbxl3 in determining mammalian circadian period. Science, 316, 897-900.
103. Siepka, S.M., Yoo, S.H., Park, J., Song, W., Kumar, V., Hu, Y., Lee, C. and Takahashi, J.S. (2007) Circadian mutant overtime reveals F-box protein FBXL3 regulation of cryptochrome and period gene expression. Cell, 129, 1011-1023.
104. Maywood, E.S., Chesham, J.E., Meng, Q.J., Nolan, P.M., Loudon, A.S. and Hastings, M.H. (2011) Tuning the period of the mammalian circadian clock: additive and independent effects of CK1{varepsilon}Tau and Fbxl3Afh mutations on mouse circadian behavior and molecular pacemaking. J. Neurosci., 31, 1539-1544.
105. Pritchett, D., Wulff, K., Oliver, P.L., Bannerman, D.M., Davies, K.E., Harrison, P.J., Peirson, S.N. and Foster, R.G. (2012) Evaluating the links between schizophrenia and sleep and circadian rhythm disruption. J. Neural. Transm. May 10. [Epub ahead of print].
106. Oliver, P.L., Sobczyk, M.V., Maywood, E.S., Edwards, B., Lee, S., Livieratos, A., Oster, H., Butler, R., Godinho, S.I., Wulff, K. et al. (2012) Disrupted circadian rhythms in a mouse model of schizophrenia. Curr. Biol., 22, 314-319.
107. Wulff, K. and Joyce, E. (2011) Circadian rhythms and cognition in schizophrenia. Br. J. Psychiatry, 198, 250-252.
108. Roybal, K., Theobold, D., Graham, A., DiNieri, J.A., Russo, S.J., Krishnan, V., Chakravarty, S., Peevey, J., Oehrlein, N., Birnbaum, S. et al. (2007) Mania-like behavior induced by disruption of CLOCK. Proc. Natl Acad. Sci. USA, 104, 6406-6411.
109. Keers, R., Pedroso, I., Breen, G., Aitchison, K.J., Nolan, P.M., Cichon, S., Nothen, M.M., Rietschel, M., Schalkwyk, L.C. and Fernandes, C. (2012) Reduced anxiety and depression-like behaviours in the circadian period mutant mouse afterhours. PLoS ONE, 7, e38263.
110. St Johnston, D. (2002) The art and design of genetic screens: Drosophila melanogaster. Nat. Rev. Genet., 3, 176-188.
111. Rubio-Aliaga, I., Soewarto, D., Wagner, S., Klaften, M., Fuchs, H., Kalaydjiev, S., Busch, D.H., Klempt, M., Rathkolb, B., Wolf, E. et al. (2007) A genetic screen for modifiers of the delta1-dependent notch signaling function in the mouse. Genetics, 175, 1451-1463.
112. Hafezparast, M., Klocke, R., Ruhrberg, C., Marquardt, A., Ahmad-Annuar, A., Bowen, S., Lalli, G., Witherden, A.S., Hummerich, H., Nicholson, S. et al. (2003) Mutations in dynein link motor neuron degeneration to defects in retrograde transport. Science, 300, 808-812.
113. Ravikumar, B., Acevedo-Arozena, A., Imarisio, S., Berger, Z., Vacher, C., O'Kane, C.J., Brown, S.D. and Rubinsztein, D.C. (2005) Dynein mutations impair autophagic clearance of aggregate-prone proteins. Nat. Genet., 37, 771-776.
114. Kieran, D., Hafezparast, M., Bohnert, S., Dick, J.R., Martin, J., Schiavo, G., Fisher, E.M. and Greensmith, L. (2005) A mutation in dynein rescues axonal transport defects and extends the life span of ALS mice. J. Cell Biol., 169, 561-567.
115. Liu, X., Dobbie, M., Tunningley, R., Whittle, B., Zhang, Y., Ittner, L.M. and Gotz, J. (2011) ENU mutagenesis screen to establish motor phenotypes in wild-type mice and modifiers of a pre-existing motor phenotype in tau mutant mice. J. Biomed. Biotechnol., 2011, 130947.
116. Ittner, L.M., Fath, T., Ke, Y.D., Bi, M., van Eersel, J., Li, K.M., Gunning, P. and Gotz, J. (2008) Parkinsonism and impaired axonal transport in a mouse model of frontotemporal dementia. Proc. Natl Acad. Sci. USA, 105, 15997-16002.
117. Johnson, D.K. (2005) Phenotype screening for genetically determined age-onset disorders and increased longevity in ENU-mutagenized mice. Age, 27, 15.
118. Malatynska, E., Steinbusch, H.W., Redkozubova, O., Bolkunov, A., Kubatiev, A., Yeritsyan, N.B., Vignisse, J., Bachurin, S. and Strekalova, T. (2012) Anhedonic-like traits and lack of affective deficits in 18-month-old C57BL/6 mice: implications for modeling elderly depression. Exp. Gerontol., 47, 552-564.
119. Clough, G. (1991) Suggested guidelines for the housing and husbandry of rodents for aging studies. Neurobiol. Aging, 12, 653-658.
120. Fairfield, H., Gilbert, G.J., Barter, M., Corrigan, R.R., Curtain, M., Ding, Y., D'Ascenzo, M., Gerhardt, D.J., He, C., Huang, W. et al. (2011) Mutation discovery in mice by whole exome sequencing. Genome Biol., 12, R86.
121. Belgard, T.G., Marques, A.C., Oliver, P.L., Abaan, H.O., Sirey, T.M., Hoerder-Suabedissen, A., Garcia-Moreno, F., Molnar, Z., Margulies, E.H. and Ponting, C.P. (2011) A transcriptomic atlas of mouse neocortical layers. Neuron, 71, 605-616.
122. Salta, E. and De Strooper, B. (2012) Non-coding RNAs with essential roles in neurodegenerative disorders. Lancet Neurol., 11, 189-200.
123. Lewis, M.A., Quint, E., Glazier, A.M., Fuchs, H., De Angelis, M.H., Langford, C., van Dongen, S., Abreu-Goodger, C., Piipari, M., Redshaw, N. et al. (2009) An ENU-induced mutation of miR-96 associated with progressive hearing loss in mice. Nat. Genet., 41, 614-618.
124. Masuya, H., Sezutsu, H., Sakuraba, Y., Sagai, T., Hosoya, M., Kaneda, H., Miura, I., Kobayashi, K., Sumiyama, K., Shimizu, A. et al. (2007) A series of ENU-induced single-base substitutions in a long-range cis-element altering Sonic hedgehog expression in the developing mouse limb bud. Genomics, 89, 207-214.
125. Tang, Y., Li, H. and Liu, J.P. (2010) Niemann-Pick Disease Type C: from molecule to clinic. Clin. Exp. Pharmacol. Physiol., 37, 132-140.
126. Maue, R.A., Burgess, R.W., Wang, B., Wooley, C.M., Seburn, K.L., Vanier, M.T., Rogers, M.A., Chang, C.C., Chang, T.Y., Harris, B.T. et al. (2012) A novel mouse model of Niemann-Pick type C disease carrying a D1005G-Npc1 mutation comparable to commonly observed human mutations. Hum. Mol. Genet., 21, 730-750.
127. Lewis, S. (2012) Neurological disorders: SHANK2 misbehaves in autism. Nat. Rev. Neurosci., 13, 517.
128. Xu, X., Kedlaya, R., Higuchi, H., Ikeda, S., Justice, M.J., Setaluri, V. and Ikeda, A. (2010) Mutation in archain 1, a subunit of COPI coatomer complex, causes diluted coat color and Purkinje cell degeneration. PLoS Genet., 6, e1000956.
129. Xie, G., Clapcote, S.J., Nieman, B.J., Tallerico, T., Huang, Y., Vukobradovic, I., Cordes, S.P., Osborne, L.R., Rossant, J., Sled, J.G. et al. (2007) Forward genetic screen of mouse reveals dominant missense mutation in the P/Q-type voltage-dependent calcium channel, CACNA1A. Genes Brain Behav., 6, 717-727.
130. Groszer, M., Keays, D.A., Deacon, R.M., de Bono, J.P., Prasad-Mulcare, S., Gaub, S., Baum, M.G., French, C.A., Nicod, J., Coventry, J.A. et al. (2008) Impaired synaptic plasticity and motor learning in mice with a point mutation implicated in human speech deficits. Curr. Biol., 18, 354-362.
131. Zarbalis, K., Siegenthaler, J.A., Choe, Y., May, S.R., Peterson, A.S. and Pleasure, S.J. (2007) Cortical dysplasia and skull defects in mice with a Foxc1 allele reveal the role of meningeal differentiation in regulating cortical development. Proc. Natl Acad. Sci. USA, 104, 14002-14007.
132. Furuse, T., Wada, Y., Hattori, K., Yamada, I., Kushida, T., Shibukawa, Y., Masuya, H., Kaneda, H., Miura, I., Seno, N. et al. (2010) Phenotypic characterization of a new Grin1 mutant mouse generated by ENU mutagenesis. Eur. J. Neurosci., 31, 1281-1291.
133. Lazar, N.L., Singh, S., Paton, T., Clapcote, S.J., Gondo, Y., Fukumura, R., Roder, J.C. and Cain, D.P. (2011) Missense mutation of the reticulon-4 receptor alters spatial memory and social interaction in mice. Behav. Brain Res., 224, 73-79.
134. Swanson, D.J., Steshina, E.Y., Wakenight, P., Aldinger, K.A., Goldowitz, D., Millen, K.J. and Chizhikov, V.V. (2010) Phenotypic and genetic analysis of the cerebellar mutant tmgc26, a new ENU-induced ROR-alpha allele. Eur. J. Neurosci., 32, 707-716.
135. Edwards, A., Treiber, C.D., Breuss, M., Pidsley, R., Huang, G.J., Cleak, J., Oliver, P.L., Flint, J. and Keays, D.A. (2011) Cytoarchitectural disruption of the superior colliculus and an enlarged acoustic startle response in the Tuba1a mutant mouse. Neuroscience, 195, 191-200.
136. Keays, D.A., Cleak, J., Huang, G.J., Edwards, A., Braun, A., Treiber, C.D., Pidsley, R. and Flint, J. (2010) The role of Tuba1a in adult hippocampal neurogenesis and the formation of the dentate gyrus. Dev. Neurosci., 32, 268-277.
137. Keays, D.A., Tian, G., Poirier, K., Huang, G.J., Siebold, C., Cleak, J., Oliver, P.L., Fray, M., Harvey, R.J., Molnar, Z. et al. (2007) Mutations in alpha-tubulin cause abnormal neuronal migration in mice and lissencephaly in humans. Cell, 128, 45-57.
138. Furuse, T., Yamada, I., Kushida, T., Masuya, H., Miura, I., Kaneda, H., Kobayashi, K., Wada, Y., Yuasa, S. and Wakana, S. (2012) Behavioral and neuromorphological characterization of a novel Tuba1 mutant mouse. Behav. Brain Res., 227, 167-174.